Citigroup Inc Shockwave Medical, Inc. Transaction History

Citigroup Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$191.17 - $325.63 $96,923 - $165,094	-507 Reduced 3.01%	16,310 $5.31 Million
Q4 2023 Feb 09, 2024	BUY	$160.99 - $215.69 $2.1 Million - $2.82 Million	13,059 Added 347.5%	16,817 $3.2 Million
Q3 2023 Nov 09, 2023	SELL	$194.33 - $283.97 $2.91 Million - $4.25 Million	-14,980 Reduced 79.94%	3,758 $748,000
Q2 2023 Aug 10, 2023	BUY	$223.05 - $302.68 $2.74 Million - $3.72 Million	12,274 Added 189.88%	18,738 $5.35 Million
Q1 2023 May 11, 2023	BUY	$175.41 - $217.92 $4,736 - $5,883	27 Added 0.42%	6,464 $1.4 Million
Q4 2022 Feb 09, 2023	SELL	$204.38 - $296.82 $920,323 - $1.34 Million	-4,503 Reduced 41.16%	6,437 $1.32 Million
Q3 2022 Nov 10, 2022	BUY	$195.21 - $310.53 $914,949 - $1.46 Million	4,687 Added 74.96%	10,940 $3.04 Million
Q2 2022 Aug 10, 2022	BUY	$115.91 - $214.48 $102,928 - $190,458	888 Added 16.55%	6,253 $1.2 Million
Q1 2022 May 12, 2022	SELL	$127.96 - $207.36 $1.22 Million - $1.97 Million	-9,518 Reduced 63.95%	5,365 $1.11 Million
Q4 2021 Feb 10, 2022	BUY	$165.13 - $241.83 $787,009 - $1.15 Million	4,766 Added 47.11%	14,883 $2.65 Million
Q3 2021 Nov 10, 2021	BUY	$163.99 - $235.57 $1.66 Million - $2.38 Million	10,117 New	10,117 $2.08 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.